Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
zinc finger protein 285B (pseudogene) | 1.000 | 0.077 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||||||
|
ribosomal protein L32 pseudogene 1 | 1.000 | 0.077 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||||||
|
major histocompatibility complex, class II, DQ beta 3 | 0.931 | 0.192 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||||||
|
YdjC chitooligosaccharide deacetylase homolog | 0.805 | 0.231 | 6.2E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
major histocompatibility complex, class II, DP alpha 3 (pseudogene) | 0.805 | 0.308 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
hydroxysteroid 17-beta dehydrogenase 8 | 0.805 | 0.346 | 3.7E-05 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2011 | 2011 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit gamma3 | 0.711 | 0.423 | 0.85 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
ring finger protein 1 | 0.653 | 0.423 | 0.65 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2011 | 2011 | ||||||||
|
G protein signaling modulator 3 | 0.751 | 0.423 | 0.29 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
collagen type XI alpha 2 pseudogene 1 | 0.805 | 0.462 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2011 | 2013 | |||||||||
|
EHMT2 and SLC44A4 antisense RNA 1 | 0.780 | 0.462 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||||||
|
HBS1 like translational GTPase | 0.705 | 0.462 | 1.9E-07 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
gametogenetin binding protein 1 (pseudogene) | 0.769 | 0.462 | 0.69 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
long intergenic non-protein coding RNA 2571 | 0.743 | 0.500 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||||||
|
major histocompatibility complex, class II, DO beta | 0.705 | 0.500 | 1.9E-06 |
|
disease | 0.110 | None | 1.000 | 1 | 2 | 2013 | 2017 | ||||||||
|
major histocompatibility complex, class II, DP beta 2 (pseudogene) | 0.743 | 0.500 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2011 | 2011 | |||||||||
|
major histocompatibility complex, class II, DP alpha 2 (pseudogene) | 0.780 | 0.538 |
|
disease | 0.100 | None | 1.000 | 3 | 4 | 2009 | 2018 | |||||||||
|
cholinergic receptor nicotinic epsilon subunit | 0.636 | 0.577 | 4.7E-09 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
surfactant associated 2 | 0.695 | 0.577 | 3.6E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
glucokinase regulator | 0.604 | 0.615 | 8.5E-19 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
ubiquitin conjugating enzyme E2 L3 | 0.644 | 0.615 | 0.84 |
|
disease | 0.140 | None | 1.000 | 1 | 17 | 2013 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||||||
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
glycoprotein Ib platelet subunit alpha | 0.565 | 0.692 | 3.2E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
RNA binding fox-1 homolog 1 | 0.584 | 0.692 | 0.95 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 |